Spontaneous acute tumor lysis syndrome as a cause of early deaths in short-term carcinogenicity studies using p53 +/- mice.

作者: P. Vogel , J. M. Pletcher , Y. Liang

DOI: 10.1177/0300985810363484

关键词: LeukemiaHigh incidenceBiologyToxicityPathogenesisCarcinogenLymphomaPathologyTumor lysis syndromeHistopathology

摘要: Acute tumor lysis syndrome (ATLS) is a potentially lethal condition precipitated by the massive release of intracellular components such as nucleic acids, potassium, and phosphorus, following rapid widespread cells. Herein, authors describe high incidence characteristic histopathologic lesions acute ATLS in p53-deficient mice used 2 short-term carcinogenicity studies. was frequent cause early death p53 þ/– these studies consistently associated with presence disseminated lymphoma leukemia. Although heavy burden leukemia were present all affected mice, absence other equally severe indicates that burdens are necessary but insufficient to mice. The hallmark findings microemboli composed nuclear cytoplasmic debris derived from lysed mechanical obstruction capillary beds appeared be proximate deaths Microemboli may contribute pathogenesis renal failure clinical signs species. Recognition laboratory animals critical intended evaluate efficacy and/or toxicity anticancer treatments, where due might otherwise attributed test article toxicity. Further on role elucidate pathogenetic mechanisms lead improved approaches management treatment this condition.

参考文章(33)
C J Piek, E Teske, Tumor lysis syndrome in a dog Tijdschrift Voor Diergeneeskunde. ,vol. 121, pp. 64- 66 ,(1996)
Tennant Rw, French Je, Spalding Jw, Mennear J, Stasiewicz S, Genetically altered mouse models for identifying carcinogens. IARC scientific publications. pp. 123- ,(1999)
CA Purdie, DJ Harrison, A Peter, L Dobbie, S White, SE Howie, DM Salter, CC Bird, AH Wyllie, ML Hooper, None, Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene Oncogene. ,vol. 9, pp. 603- 609 ,(1994)
Lawrence F. Cohen, James E. Balow, Ian T. Magrath, David G. Poplack, John L. Ziegler, Acute tumor lysis syndrome The American Journal of Medicine. ,vol. 68, pp. 486- 491 ,(1980) , 10.1016/0002-9343(80)90286-7
Michael B Davidson, Snehal Thakkar, John K Hix, Naveen D Bhandarkar, Alan Wong, Martin J Schreiber, Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome The American Journal of Medicine. ,vol. 116, pp. 546- 554 ,(2004) , 10.1016/J.AMJMED.2003.09.045
Lawrence A. Donehower, The p53-deficient mouse: a model for basic and applied cancer studies. Seminars in Cancer Biology. ,vol. 7, pp. 269- 278 ,(1996) , 10.1006/SCBI.1996.0035
A ALTMAN, Acute tumor lysis syndrome Seminars in Oncology. ,vol. 28, pp. 3- 8 ,(2001) , 10.1016/S0093-7754(01)90254-4
Lorne J Hofseth, S.Perwez Hussain, Curtis C Harris, p53: 25 years after its discovery. Trends in Pharmacological Sciences. ,vol. 25, pp. 177- 181 ,(2004) , 10.1016/J.TIPS.2004.02.009
Norbert Lameire, Wim Van Biesen, Raymond Vanholder, Acute renal problems in the critically ill cancer patient Current Opinion in Critical Care. ,vol. 14, pp. 635- 646 ,(2008) , 10.1097/MCC.0B013E32830EF70B
Alison M. LaCarrubba, Philip J. Johnson, Marlyn S. Whitney, Margaret A. Miller, Jimmy C. Lattimer, Hypoglycemia and tumor lysis syndrome associated with peritoneal mesothelioma in a horse. Journal of Veterinary Internal Medicine. ,vol. 20, pp. 1018- 1022 ,(2006) , 10.1111/J.1939-1676.2006.TB01822.X